William D. Humphries
Mr. Humphries has served as a director of Clearside since 2012 and as the Chair of our Board of Directors from 2018 to June 2023. He currently serves as the Chief Executive Officer of MedPharm, a global contract development and manufacturing organization. Prior to MedPharm, Mr. Humphries’ executive leadership roles included serving as CEO and Board Director at Alcami Corporation, CEO at Isosceles Pharmaceuticals, President and Group Company Chairman of Ortho Dermatologics, CEO of Merz North America, President of Stiefel, a GSK Company, and Vice President of U.S. Skincare at Allergan Pharmaceuticals. Mr. Humphries is an experienced leader in the life sciences industry and currently serves as a member of the Board of Directors at Aclaris Therapeutics. He previously served as a member of the board of directors of PhaseBio Pharmaceuticals, Inc., STRATA Skin Sciences, SKNV and Bryn Pharmaceuticals. Mr. Humphries received his M.B.A. degree from Pepperdine University and a B.A. degree from Bucknell University.